The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis

Vascular Pharmacology

Volumn 106, Issue , 2018, Pages 1-8

  Wesseling, M ^a   Sakkers, T R ^a   de Jager, S C A ^a   Pasterkamp, G ^a   Goumans, M J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TAZ; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR YAP; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; ZINC FINGER E BOX BINDING HOMEOBOX;

APICAL MEMBRANE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BASEMENT MEMBRANE; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CELL POLARITY; CYTOSKELETON; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TGF BETA SIGNALING; ANIMAL; ARTERY; CELL ADHESION; CELL MOTION; METABOLISM; PATHOLOGY; PHENOTYPE; SIGNAL TRANSDUCTION; VASCULAR REMODELING;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; CELL ADHESION; CELL MOVEMENT; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; HUMANS; PHENOTYPE; PLAQUE, ATHEROSCLEROTIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; VASCULAR REMODELING;

EID: 85042588012     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2018.02.006     Document Type: Review

References (61)

1. Huang, R.Y., Guilford, P., Thiery, J.P., Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J. Cell Sci. 125:Pt 19 (2012 Oct 1), 4417–4422.
2. Lamouille, S., Xu, J., Derynck, R., Molecular mechanisms of epithelial–mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15:3 (2014), 178–196.
3. Mayor, R., Etienne-Manneville, S., The front and rear of collective cell migration. Nat. Rev. Mol. Cell Biol. 17:2 (2016 Feb), 97–109.
4. Yilmaz, M., Christofori, G., EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 28:1–2 (2009), 15–33.
5. Xu, J., Lamouille, S., Derynck, R., TGF-β-induced epithelial to mesenchymal transition. Cell Res. 19:2 (2009), 156–172.
6. Kalluri, R., Weinberg, R.A., The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119:6 (2009 Jun), 1420–1428.
7. Potenta, S., Zeisberg, E., Kalluri, R., The role of endothelial-to-mesenchymal transition in cancer progression. Br. J. Cancer 99:9 (2008), 1375–1379.
8. Chen, P.Y., Qin, L., Baeyens, N., Li, G., Afolabi, T., Budatha, M. et al., Endothelial-to-mesenchymal transition drives atherosclerosis progression. J. Clin. Invest. 125:12 (2015 Oct 26), 4514–4528.
9. Evrard, S.M., Lecce, L., Michelis, K.C., Nomura-Kitabayashi, A., Pandey, G., Purushothaman, K. et al., Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat. Commun., 7, 2016, 11853.
10. Kitao, A., Sato, Y., Sawada-Kitamura, S., Harada, K., Sasaki, M., Morikawa, H. et al., Endothelial to mesenchymal transition via transforming growth factor-β1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am. J. Pathol. 175:2 (2009), 616–626.
11. Nieto, M.A., Epithelial plasticity: a common theme in embryonic and cancer cells. Science, 342(6159), 2013 Nov 8, 1234850.
12. Zheng, H., Kang, Y., Multilayer control of the EMT master regulators. Oncogene 33:14 (2014 Apr 3), 1755–1763.
13. Goumans, M., Ten Dijke, P., TGF-β signaling in control and cardiovascular function. Cold Spring Harb. Perspect. Biol., 10(2), 2018 Feb 1, 10.1101/cshperspect.a022210 pii: a022210.
14. Oh, S.P., Seki, T., Goss, K.A., Imamura, T., Yi, Y., Donahoe, P.K. et al., Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 97:6 (2000 Mar 14), 2626–2631.
15. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., ten Dijke, P., Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21:7 (2002 Apr 2), 1743–1753.
16. Massagué J., TGFβ signalling in context. Nat. Rev. Mol. Cell Biol. 13:10 (2012), 616–630.
17. Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C.H., Moustakas, A., TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16:4 (2005 Apr), 1987–2002.
18. Feng, X., Derynck, R., Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21 (2005), 659–693.
19. Thuault, S., Valcourt, U., Petersen, M., Manfioletti, G., Heldin, C.H., Moustakas, A., Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J. Cell Biol. 174:2 (2006 Jul 17), 175–183.
20. Bakin, A.V., Tomlinson, A.K., Bhowmick, N.A., Moses, H.L., Arteaga, C.L., Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275:47 (2000 Nov 24), 36803–36810.
21. Lamouille, S., Subramanyam, D., Blelloch, R., Derynck, R., Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs. Curr. Opin. Cell Biol. 25:2 (2013), 200–207.
22. Zhou, B.P., Deng, J., Xia, W., Xu, J., Li, Y.M., Gunduz, M. et al., Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial–mesenchymal transition. Nat. Cell Biol. 6:10 (2004), 931–940.
23. Peinado, H., Olmeda, D., Cano, A., Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat. Rev. Cancer 7:6 (2007), 415–428.
24. Zhang, H., von Gise, A., Liu, Q., Hu, T., Tian, X., He, L. et al., Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion. J. Biol. Chem. 289:27 (2014 Jul 4), 18681–18692.
25. Vincent, T., Neve, E.P., Johnson, J.R., Kukalev, A., Rojo, F., Albanell, J. et al., A SNAIL1–SMAD3/4 transcriptional repressor complex promotes TGF-β mediated epithelial–mesenchymal transition. Nat. Cell Biol. 11:8 (2009), 943–950.
26. Chen, Z.F., Behringer, R.R., Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9:6 (1995 Mar 15), 686–699.
27. Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C. et al., Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117:7 (2004), 927–939.
28. Eger, A., Aigner, K., Sonderegger, S., Dampier, B., Oehler, S., Schreiber, M. et al., DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24:14 (2005), 2375–2385.
29. Dave, N., Guaita-Esteruelas, S., Gutarra, S., Frias, A., Beltran, M., Peiro, S. et al., Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J. Biol. Chem. 286:14 (2011 Apr 8), 12024–12032.
30. Li, Z., Wang, Y., Zhu, Y., Yuan, C., Wang, D., Zhang, W. et al., The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer. Mol. Oncol. 9:6 (2015 Jun), 1091–1105.
31. Ramjee, V., Li, D., Manderfield, L.J., Liu, F., Engleka, K.A., Aghajanian, H. et al., Epicardial YAP/TAZ orchestrate an immunosuppressive response following myocardial infarction. J. Clin. Invest. 127:3 (2017 Mar 1), 899–911.
32. Mescher, A.L., Junqueira's Basic Histology: Text and Atlas. McGraw-Hill, 2013.
33. Umeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M. et al., ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 126:4 (2006), 741–754.
34. Kokudo, T., Suzuki, Y., Yoshimatsu, Y., Yamazaki, T., Watabe, T., Miyazono, K., Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J. Cell Sci. 121:Pt 20 (2008 Oct 15), 3317–3324.
35. Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H.E.M., Behrens, J. et al., Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4:3 (2002), 222–231.
36. Marambaud, P., Shioi, J., Serban, G., Georgakopoulos, A., Sarner, S., Nagy, V. et al., A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21:8 (2002 Apr 15), 1948–1956.
37. Wheelock, M.J., Shintani, Y., Maeda, M., Fukumoto, Y., Johnson, K.R., Cadherin switching. J. Cell Sci. 121:Pt 6 (2008 Mar 15), 727–735.
38. Zeisberg, E.M., Tarnavski, O., Zeisberg, M., Dorfman, A.L., McMullen, J.R., Gustafsson, E. et al., Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat. Med. 13:8 (2007), 952–961.
39. Meng, W., Takeichi, M., Adherens junction: molecular architecture and regulation. Cold Spring Harb. Perspect. Biol., 1(6), 2009 Dec, a002899.
40. Bax, N.A., Pijnappels, D.A., Van Oorschot, A.A., Winter, E.M., de Vries, A.A., van Tuyn, J. et al., Epithelial-to-mesenchymal transformation alters electrical conductivity of human epicardial cells. J. Cell. Mol. Med. 15:12 (2011), 2675–2683.
41. Schmidt, A., Hall, A., Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 16:13 (2002 Jul 1), 1587–1609.
42. Nelson, W.J., Remodeling epithelial cell organization: transitions between front-rear and apical-basal polarity. Cold Spring Harb. Perspect. Biol., 1(1), 2009 Jul, a000513.
43. Yang, X., Pursell, B., Lu, S., Chang, T.K., Mercurio, A.M., Regulation of beta 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition. J. Cell Sci. 122:Pt 14 (2009 Jul 15), 2473–2480.
44. Maschler, S., Wirl, G., Spring, H., Bredow, D.V., Sordat, I., Beug, H. et al., Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene 24:12 (2005), 2032–2041.
45. Mise, N., Savai, R., Yu, H., Schwarz, J., Kaminski, N., Eickelberg, O., Zyxin is a transforming growth factor-beta (TGF-beta)/Smad3 target gene that regulates lung cancer cell motility via integrin alpha5beta1. J. Biol. Chem. 287:37 (2012 Sep 7), 31393–31405.
46. Koenig, A., Mueller, C., Hasel, C., Adler, G., Menke, A., Collagen type I induces disruption of E-cadherin-mediated cell-cell contacts and promotes proliferation of pancreatic carcinoma cells. Cancer Res. 66:9 (2006 May 1), 4662–4671.
47. Nistico, P., Bissell, M.J., Radisky, D.C., Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb. Perspect. Biol., 4(2), 2012 Feb 1, 10.1101/cshperspect.a011908.
48. Sheppard, D., Integrin-mediated activation of latent transforming growth factor β. Cancer Metastasis Rev. 24:3 (2005), 395–402.
49. Zeisberg, E.M., Potenta, S.E., Sugimoto, H., Zeisberg, M., Kalluri, R., Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J. Am. Soc. Nephrol. 19:12 (2008 Dec), 2282–2287.
50. Iwano, M., Plieth, D., Danoff, T.M., Xue, C., Okada, H., Neilson, E.G., Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest. 110:3 (2002 Aug), 341–350.
51. Kalluri, R., Neilson, E.G., Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112:12 (2003 Dec), 1776–1784.
52. Rastaldi, M.P., Ferrario, F., Giardino, L., Dell'Antonio, G., Grillo, C., Grillo, P. et al., Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int. 62:1 (2002), 137–146.
53. Thiery, J.P., Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2(6), 2002, 442.
54. Markwald, R.R., Fitzharris, T.P., Manasek, F.J., Structural development of endocardial cushions. Dev. Dyn. 148:1 (1977), 85–119.
55. Kisanuki, Y.Y., Hammer, R.E., Miyazaki, J., Williams, S.C., Richardson, J.A., Yanagisawa, M., Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev. Biol. 230:2 (2001), 230–242.
56. Piera-Velazquez, S., Li, Z., Jimenez, S.A., Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am. J. Pathol. 179:3 (2011), 1074–1080.
57. Chen, P., Qin, L., Barnes, C., Charisse, K., Yi, T., Zhang, X. et al., FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep. 2:6 (2012), 1684–1696.
58. Cooley, B.C., Nevado, J., Mellad, J., Yang, D., St Hilaire, C., Negro, A. et al., TGF-beta signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling. Sci. Transl. Med., 6(227), 2014 Mar 12, 227ra34.
59. Chen, P., Qin, L., Tellides, G., Simons, M., Fibroblast growth factor receptor 1 is a key inhibitor of TGFb signaling in the endothelium. Sci. Signal, 6(227), 2014 Mar 12, 227ra34.
60. Mori, H., Torii, S., Kutyna, M., Sakamoto, A., Finn, A.V., Virmani, R., Coronary artery calcification and its progression: what does it really mean?. JACC Cardiovasc. Imaging 11:1 (2018 Jan), 127–142.
61. Moonen, J.R., Lee, E.S., Schmidt, M., Maleszewska, M., Koerts, J.A., Brouwer, L.A. et al., Endothelial-to-mesenchymal transition contributes to fibro-proliferative vascular disease and is modulated by fluid shear stress. Cardiovasc. Res. 108:3 (2015 Dec 1), 377–386.